Journal of Preventive, Diagnostic and Treatment Strategies in Medicine       

Learn more ..

 

About the Journal

​Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, a publication of Society of Biomedical & Biotechnology Scientists (SBBS) (https://www.sbbs-soc.com), is a peer-reviewed print + online Quarterly journal. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional / subject-based repository.

Journal Ethics

Wolters Kluwer and Journal/Association are committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp

Open Access Publication and Creative Commons Licensing

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Digital Archiving

Wolters Kluwer Medknow provides for long-term digital preservation through two primary partnerships, Portico and CLOCKSS.

Portico is a leading digital preservation service worldwide. The content is preserved as an archival version and is not publically accessible via Portico, but is provided when required under specific conditions, such as discontinuation of the collection or catastrophic failure of the website.

CLOCKSS will enable any library to maintain their own archive of content from Wolters Kluwer Medknow and other publishers, with minimal technical effort and using cheaply available hardware.

Ahead of Print Policy

Articles published online under the Ahead of Print model are considered published and can be cited and quoted using the DOI as the reference source. Wolters Kluwer Medknow has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.

Advertisements

While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

  • "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
  • The Editorial Board has full and final approval over the content of all advertisements.
  • Advertisers will never be shown any manuscripts or other content prior to publication.

Scope of the Journal

The Journal of Preventive, Diagnostic and Treatment Strategies in Medicine aims to publish current Research strategies related to medical and health studies. It aims to promote communication among clinical researchers, physicians and biologist, that works in areas related to improve health quality and open the line between old and new strategies in medicine worldwide.

Journal of preventive diagnostic and treatment strategies in medicine(JPDTSM)) includes:

  • New strategies Related  to virus infection 
  • New strategies Related  to infectious diseases
  • New strategies Related  to Cancer treatment 
  • New strategies in medical treatment 
  • New strategies Related  to Molecular Biology
  • New strategies Related  to Physiology/Biochemistry
  • New strategies Related  to Biochemical Engineering/Bioprocess Engineering
  • New strategies Related  to Computational Chemistry and Molecular Drug Design for better treatment 
  • New strategies Related  to Genomics and molecular Bioinformatics for medical biodata
  • New strategies Related  to Biomarkers studies 
  • New strategies Related  to Basics studies on tissue modeling 
  • New strategies Related  to Proteomics design 

Medknow Publications

Medknow, part of Wolters Kluwer Health, is one of the largest open access publishers worldwide with more than 450+ medical journals in its portfolio. Students, researchers, clinicians and other healthcare professionals worldwide access Medknow journals to help them fuel new discoveries and improve patient care.

Founded in 1997, Medknow is a well-respected medical publisher that fully supports many of the popular open access models through its peer-review management system. Medknow’s open access policy has resulted in more than a half a million article downloads monthly for all of its journals.

Wolters Kluwer Health (Philadelphia, PA) is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Lippincott Williams & Wilkins, Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons®, Pharmacy OneSource®, Lexicomp® and ProVation® Medical. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with annual revenues (2019) of €3.4 billion ($4.7 billion), approximately 19,000 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America.

Medknow Specialties

Online and Print Scholarly Publishing, Peer-Review System, Specialized in Medical Research, Largest Open Access Publisher.